Oncology Biosimilars Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Oncology Biosimilars market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.2% during the forecast period.

    This report presents the market size and development trends by detailing the Oncology Biosimilars market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Oncology Biosimilars market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Oncology Biosimilars industry and will help you to build a panoramic view of the industrial development.

    Oncology Biosimilars Market, By Type:

    • G-CSF

    • Hematopoietic Agents

    • Monoclonal Antibodies

    Oncology Biosimilars Market, By Application:

    • Retail Pharmacies

    • Hospital Pharmacies

    • Online Pharmacies

    Some of the leading players are as follows:

    • Sandoz International GmbH

    • BIOCAD

    • STADA Arzneimittel AG

    • Biocon

    • Teva Pharmaceutical Industries Ltd

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Biosimilars Market

    • 1.3 Market Segment by Type

      • 1.3.1 G-CSF

      • 1.3.2 Hematopoietic Agents

      • 1.3.3 Monoclonal Antibodies

    • 1.4 Market Segment by Application

      • 1.4.1 Retail Pharmacies

      • 1.4.2 Hospital Pharmacies

      • 1.4.3 Online Pharmacies

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oncology Biosimilars Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Biosimilars by Major Types

      • 3.4.1 G-CSF

      • 3.4.2 Hematopoietic Agents

      • 3.4.3 Monoclonal Antibodies

    4 Segmentation of Oncology Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Biosimilars by Major End-Users

      • 4.4.1 Retail Pharmacies

      • 4.4.2 Hospital Pharmacies

      • 4.4.3 Online Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Global Oncology Biosimilars Production Analysis by Top Regions

    • 5.2 Global Oncology Biosimilars Consumption Analysis by Top Regions

    • 5.3 Global Oncology Biosimilars Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Oncology Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Oncology Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Oncology Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Oncology Biosimilars Production, Import, Consumption and Export Analysis

    6 Product Circulation of Oncology Biosimilars Market among Top Countries

    • 6.1 Top 5 Export Countries in Oncology Biosimilars Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Oncology Biosimilars Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Oncology Biosimilars Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oncology Biosimilars Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Oncology Biosimilars Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Oncology Biosimilars Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Oncology Biosimilars Landscape Analysis

    • 7.1 North America Oncology Biosimilars Landscape Analysis by Top Countries

      • 7.1.1 United States Oncology Biosimilars Market Volume and Growth Rate

      • 7.1.2 Canada Oncology Biosimilars Market Volume and Growth Rate

      • 7.1.3 Mexico Oncology Biosimilars Market Volume and Growth Rate

    8. Europe Oncology Biosimilars Landscape Analysis

    • 8.1 Europe Oncology Biosimilars Landscape Analysis by Major Types

    • 8.2 Europe Oncology Biosimilars Landscape Analysis by Major End-Users

    • 8.3 Europe Oncology Biosimilars Landscape Analysis by Top Countries

      • 8.3.1 Germany Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.2 UK Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.3 France Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.4 Italy Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.5 Spain Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.6 Belgium Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.7 Poland Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.8 Russia Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.9 Turkey Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.10 Netherlands Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.11 Portugal Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.12 Denmark Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.13 Finland Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.14 Iceland Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.15 Norway Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.16 Sweden Oncology Biosimilars Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Oncology Biosimilars Landscape Analysis

    • 9.1 Asia Pacific Oncology Biosimilars Landscape Analysis by Top Countries

      • 9.1.1 China Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.2 Japan Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.4 India Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.5 ASEAN Oncology Biosimilars Market Volume and Growth Rate

      • 9.1.6 South Korea Oncology Biosimilars Market Volume and Growth Rate

    10 LAMEA Oncology Biosimilars Landscape Analysis

    • 10.1 LAMEA Oncology Biosimilars Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Oncology Biosimilars Market Volume and Growth Rate

      • 10.1.2 Brazil Oncology Biosimilars Market Volume and Growth Rate

      • 10.1.3 North Africa Oncology Biosimilars Market Volume and Growth Rate

      • 10.1.4 South Africa Oncology Biosimilars Market Volume and Growth Rate

      • 10.1.5 Argentina Oncology Biosimilars Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Sandoz International GmbH

      • 11.1.1 Sandoz International GmbH Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 BIOCAD

      • 11.2.1 BIOCAD Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 STADA Arzneimittel AG

      • 11.3.1 STADA Arzneimittel AG Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Biocon

      • 11.4.1 Biocon Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Teva Pharmaceutical Industries Ltd

      • 11.5.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 83 Figures and 206 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of G-CSF

    • Figure Market Size and Growth Rate of Hematopoietic Agents

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Figure North America Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure United States Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure France Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure China Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure India Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncology Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncology Biosimilars

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Biosimilars by Different Types from 2014 to 2026

    • Table Consumption Share of Oncology Biosimilars by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of G-CSF

    • Figure Market Size and Growth Rate of Hematopoietic Agents

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncology Biosimilars by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncology Biosimilars by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Global Oncology Biosimilars Production by Major Regions

    • Table Global Oncology Biosimilars Production Share by Major Regions

    • Table Global Oncology Biosimilars Consumption by Major Regions

    • Table Global Oncology Biosimilars Consumption Share by Major Regions

    • Table North America Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Europe Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table LAMEA Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oncology Biosimilars Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oncology Biosimilars Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oncology Biosimilars Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oncology Biosimilars Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table North America Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2014

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2018

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2026

    • Figure United States Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure France Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure China Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure India Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International GmbH

    • Figure Sales and Growth Rate Analysis of Sandoz International GmbH

    • Figure Revenue and Market Share Analysis of Sandoz International GmbH

    • Table Product and Service Introduction of Sandoz International GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCAD

    • Figure Sales and Growth Rate Analysis of BIOCAD

    • Figure Revenue and Market Share Analysis of BIOCAD

    • Table Product and Service Introduction of BIOCAD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of STADA Arzneimittel AG

    • Figure Sales and Growth Rate Analysis of STADA Arzneimittel AG

    • Figure Revenue and Market Share Analysis of STADA Arzneimittel AG

    • Table Product and Service Introduction of STADA Arzneimittel AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.